Results 121 to 130 of about 42,919 (249)

Isoniazid‐Related Secondary Drug‐Induced Autoimmune Hepatitis in a Patient Diagnosed With Ankylosing Spondylitis and Tuberculous Lymphadenitis: A Case Report

Clinical Case Reports, Volume 14, Issue 6, June 2026.
ABSTRACT Autoimmune hepatitis is a type of chronic hepatitis that is usually progressive, has unknown etiology, and can occur at any age. In the present case, drug‐associated autoimmune hepatitis (DIAIH) was discussed, and DIAIH secondary to isoniazid (INH) was found in two case reports in the literature.
Murat AY, Erhan Bozkurt
wiley   +1 more source

The Atypical and Suspicious for Malignancy Categories of the WHO Reporting System for Lymph Node, Spleen, and Thymus Cytopathology: Review of their Diagnostic Utility, Limitations, and Clinical Impact

Diagnostic Cytopathology, Volume 54, Issue 6, Page 449-460, June 2026.
ABSTRACT Background Fine‐needle aspiration biopsy (FNAB) is the preferred first‐line diagnostic tool for evaluating lymphadenopathy due to its minimally invasive nature and cost‐effectiveness. However, cytopathological interpretation of lymph node FNAB remains challenging because of the wide morphological spectrum of lymphoid lesions.
Immacolata Cozzolino, Mats Ehinger, Oscar Lin, Elisabetta Maffei, Pio Zeppa, Andrew S. Field   +5 more
wiley   +1 more source

Artificial Sweeteners and Autoimmune Diseases: Insights From Integrative Bioinformatics and Mendelian Randomization

Food Science &Nutrition, Volume 14, Issue 6, June 2026.
This study provides a novel molecular perspective on the role of AS in ADs development. We identified a positive association between artificially sweetened cereal intake and ADs risk and revealed multiple pathogenic mechanisms involving apoptosis, inflammatory signaling, immune activation, and gut microbiota dysbiosis.
Yupei Liu, Jizhen Huang, Xue Hu, Shan Tian, Jiao Li, Shiyun Tan, Weiguo Dong   +6 more
wiley   +1 more source

Predicting immune-related thyroiditis using polygenic risk scores in patients with advanced melanoma. [PDF]

J Immunother Cancer
Tarhini AA, Khaksar MA, Chen Z, Lee SJ, Stephen Hodi F, Li T, Yoder SJ, Streicher H, Sondak VK, Kirkwood JM, Wang X, Kanetsky PA.   +11 more
europepmc   +1 more source

Combined Detection of Preoperative Serum Calcitonin and Carcinoembryonic Antigen in Medullary Thyroid Carcinoma: A Retrospective Multicenter Cohort Study

Health Care Science, Volume 5, Issue 3, Page 223-230, June 2026.
Compared with the detection of either marker alone, the combined detection of calcitonin (Ctn) and carcinoembryonic antigen (CEA) improved the diagnostic accuracy for medullary thyroid cancer (MTC) but did not enhance the positive predictive value (PPV).
Yu Yang, Yufei He, Bo Lin, Yuanyuan Zheng, Xinyi Deng, Wenxin Chen, Zhenbang Ke, Yue Qiu, Yuting Hong, Jiayuan Zhang, Guojie Dong, Siqi Qiao, Ziyi Xin, Xuyang Li, Tianyi Xu, Wenke Chen, Xinwen Chen, Yingtong Hou, Fenghua Lai, Jianyan Long, Zhanqiang Zhang, Xiangdong Xu, Yihao Liu   +22 more
wiley   +1 more source

Adrenal insufficiency influences the pattern of thyrotoxicosis toward triiodothyronine predominance. [PDF]

JCEM Case Rep
Maruoka A, Nishimura K, Mukai C, Takahashi K, Irie J, Toyoda N.   +5 more
europepmc   +1 more source

Thyroid storm triggered by immune checkpoint inhibitor therapy. [PDF]

BMJ Case Rep
Hagiwara J, Sekine M, Sakawaki E, Sakawaki S, Takeyama Y.   +4 more
europepmc   +1 more source

Maternal and Neonatal Outcomes of Immune Thrombocytopenia in Pregnancy: A Five‐Year Single‐Center Cross‐Sectional Study

Health Science Reports, Volume 9, Issue 6, June 2026.
ABSTRACT Objectives Immune thrombocytopenia (ITP) during pregnancy presents unique management challenges. This study represents the first analysis of ITP outcomes during pregnancy in Qatar, aiming to assess maternal and neonatal outcomes at a tertiary care center.
Sara Elkorashi, Hassan Magboul, Abdulrahman F. Al‐Mashdali, Mohammed Alnajjar, Naela AlMallahi, Elmustafa Abdalla, Dina Sameh Soliman, Sara Aldali, Manar Elsheikh, Honar Cherif, Shehab F. Mohamed   +10 more
wiley   +1 more source

Efficacy of Ritlecitinib for Vitiligo Treatment Stratified by Baseline Demographic and Clinical Characteristics: Post Hoc Analysis of a Phase 2b Study

JEADV Clinical Practice, Volume 5, Issue 2, Page 571-576, June 2026.
This post hoc analysis examined the efficacy of ritlecitinib in subgroups of patients with vitiligo, defined by demographic and clinical characteristics. Patients completed the dose‐ranging and extension periods of the phase 2b study (NCT03715829) of ritlecitinib.
A. G. Pandya, I. Hamzavi, P. Ghosh, K. Ezzedine, J. E. Harris, R. Adiri, S. Chen, E. Peeva, Y. Yamaguchi   +8 more
wiley   +1 more source

Artemisinin-Related Therapeutic Strategies for Autoimmune Thyroiditis: Chemokine-Receptor Networks, Spatial Thyroid Biology, and Molecular Mechanisms. [PDF]

Drug Des Devel Ther
Sun Y, Yang X, Zhu Q, Yang R.
europepmc   +1 more source